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BILE acids, or their degradation pro-
ducts bythe gutbacterialflora, mayplay a
role in the pathogenesis of colorectal can-
cer (Hill, 1975). In animals, intra-rectal
instillations of taurocholic or lithocholic
acids (Narisawa et al., 1974; Reddy et al.
1977) or oral administration of cholic acid
(Cohen et al., 1980) significantly increase
the rate of chemically induced intestinal
tumours. These data led us to study the
effect of dietary chenodeoxycholic acid
(CDCA) in experimental carcinogenesis
of the intestine, all the more as CDCA,
orally administered for months and years,
is used in the treatment of human gall-
stones.
Experimental design
Standard diet (Extralabo) supplement-
ed or not with CDCA, was given to 40
hybrid Fl (C57BL6/DBA2) mice and 75
golden hamsters. Three concentrations of
CDCA were used, 250 pt/106 in mice, 750
and 2500 pt/106 in hamsters. In cocarcino-
genesis experiments, control or CDCA-
treated animals received weekly s.c. injec-
tions of 1.2 dimethylhydrazine (DMH), 10
mg/kg inmice, 20mg/kg inhamsters. Nec-
ropsies were performed on all sacrificed
animals; some animals found dead and
autolysed were not included in the results.
Fisher's exact-probability and non-para-
metric U tests were respectively used to
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compare the prevalence of lesions and the
number of tumours per animal.
Administration ofCDCA alone
Ten mice were fed with 250 pt/106
CDCA for 54 weeks, 10 hamsters with 750
pt/106 CDCA for 25 weeks and 10hamsters
with 2500 pt/106 CDCA for 21 weeks. No
intestinal tumour was found in any CDCA
fed animals, nor in standard diet controls.
The experiment was shortenedin hamsters
by CDCA-induced hepatotoxicity, with
degenerative hepatitis, chiefly in animals
fed with 2500 pt/106 CDCA.
Administration of CDCA and DMH
DMH was injected weekly for 20 weeks
in mice, 18 weeks in hamsters fed with
750 pt/106 CDCA and their controls, 13
weeks in hamsters fed with 2500 Pt/106
CDCA and their controls. The mean time
of CDCA administration was 37 weeks in
mice, 24 weeks in low-dose hamsters, 19
weeks in high-dose hamsters. The distri-
bution of colorectal lesions in the 3 experi-
mental series is reported in the Table.
In the mice all the lesions were located
in the distal colon and rectum. Few mice
had cancers (2/10 and 2/9 in control and
CDCA-fed mice), but polyps were found in
7/10 and 7/9 ofthe animals. Ifallintestinal
lesions are gathered, a statistically signifi-
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TABLE.-Distribution of colorectal lesions in DMH-treated animals
Number of lesions
NSumber of animals
CDCA X >
Species (pt/ ()f) Total Lesioni free Carcinomas DTy.splasia
Polyps
Adenomatous Hyperplasic
Mice 0
250
Hamster.s O
750
Hamsters
250(1
cant difference (P < 0.05) appears between
mice treated by DMH alone (1.7 lesions
per animal) and DMH + CDCA (3.2 lesions
per animal). However, there is no signifi-
cant difference if each type of lesion is
considered separately. Metastases were
never observed.
There was no significant difference be-
tween control and 750 pt/106 CDCA-fed
hamsters for cancer prevalence (respec-
tively 6/9 and 3/7) or the total number of
lesions (respectively2-8and 2-7 peranimal).
Two hamsters treated by DMH alone had
distant metastases. Cystic, degenerative or
necrotic liver lesions were found in 8/9
hamsters treated by DMH alone and in the
7 hamsters treated by DMH + CDCA.
Theassociation ofDMH and 2500 pt/106
CDCA was poorly tolerated by hamsters,
resulting in an early interruption of DMH
injections and sacrifice of the animals.
Control and CDCA-treated animals did not
significantly differ, either in the prevalence
of cancer (respectively 4/9 and 5/9) or in
the total number of lesions per animal
(2.3 and 2 0). Metastases were not found
in this group. Severe liver lesions were
observed in all the animals.
Our results show that CDCA given alone
does not induce benign or malignant in-
testinal tumours in mice and hamsters.
A definite conclusion is however hampered
bythelownumberofexperimental animals.
In hamsters, the experiment was shortened
by the liver toxicity of CDCA.
In hamsters, CDCA given at two
different doses had no promoting effect on
DMH-induced colorectal tumours. Here
also, the value of our experiments was
compromised by severe liver damage in-
duced by both DMH and CDCA. The
particular susceptibility of hamster liver
to DMH had previously been reported
(Winneker et al., 1977). The one result
suggesting a possible cocarcinogenic effect
of CDCA is the increase of the total
number of DMH-induced tumours in the
mice. However, the difference is signifi-
cant only if benign tumours are included.
The difference could be entirely fortuitous.
Sarval et al. (1979) found that orally
administered CDCA (2000 pt/I 06) did not
changetheprevalence ofintestinaltumours
induced by methylnitrosourea in the rat.
Extension of these results to the situa-
tion of CDCA-treated patients has to be
made with extreme care. In our experi-
ments, doses of CDCA were chosen to be
equivalent to the human therapeutic
dose, either on a body weight, or a body
surface basis, taking into account the
mean quantity offood ingested by animals.
This quantity was probably not affected
by CDCA toxicity, as the mean body-
weight gain was not reduced in CDCA-
treated animals. Liver toxicity, which
could interfere with the effect of CDCA on
the colon,islowerin humanthanin rodents,
which are less able to form the non-toxic
sulphate ester of lithocholic acid. The
main metabolites of CDCA are also dif-
ferent in man and rodents.
A systematic study of the incidence of
intestinal lesion detected by endoscopy in
CDCA-treated patients and suitable con-
trols could be the best way to answer the
question of the tumorigenic hazard of
bile acids in human.
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